JP Morgan Maintains Overweight on Elanco Animal Health, Raises Price Target to $30

Benzinga Newsdesk www.benzinga.com Positive 55.9%

Neg 0% Neu 0% Pos 55.9%

JP Morgan analyst Chris Schott maintains Elanco Animal Health (NYSE:ELAN) with a Overweight and raises the price target from $28 to $30.